04/14/2025
3:19 PM | Novavax (Subject)
YOUNG JAMES F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2025
1:52 PM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2025
7:03 PM | Novavax (Issuer)
Shiver John W. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/12/2025
7:04 PM | Novavax (Issuer)
Shiver John W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
3:33 PM | Kelly James Patrick (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
3:34 PM | Novavax (Issuer)
Trizzino John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:30 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
4:03 PM | Jacobs John C (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
4:04 PM | Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
4:07 PM | Casey Mark J (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:39 PM | Novavax (Issuer)
O'Hara Elaine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for NVAX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Novavax and its competitors with MarketBeat's FREE daily newsletter. |
03/04/2025
5:42 PM | Jacobs John C (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:43 PM | Kelly James Patrick (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:46 PM | Casey Mark J (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
7:01 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
7:05 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
6:41 AM | Novavax (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/05/2025
6:04 PM | MCGLYNN MARGARET G (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
6:06 PM | Alton Gregg H (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
12:23 PM | BlackRock, Inc. (Filed by)
Novavax (Subject)
| Form SCHEDULE 13G/A | |
01/27/2025
5:19 PM | Jacobs John C (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
6:50 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
4:41 PM | Kelly James Patrick (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:52 PM | Novavax (Issuer)
Rodgers Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:44 PM | Novavax (Issuer)
YOUNG JAMES F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:47 PM | King Rachel K. (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:02 PM | Novavax (Subject)
YOUNG JAMES F (Reporting)
| Form 144/A | |
12/30/2024
4:27 PM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2024
9:31 AM | Novavax (Subject)
YOUNG JAMES F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2024
4:24 PM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
4:24 PM | Casey Mark J (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
11:13 AM | King Rachel K. (Reporting)
Novavax (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2024
5:00 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
3:05 PM | Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2024
3:08 PM | Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
10:21 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
4:01 PM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
12:19 PM | Novavax (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/16/2024
7:00 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2024
3:08 PM | Dubovsky Filip (Reporting)
Novavax (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2024
3:47 PM | Novavax (Issuer)
Trizzino John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Silicon Valley Gold Rush (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
08/20/2024
4:06 PM | Kelly James Patrick (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
7:04 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:37 AM | Novavax (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/10/2024
5:16 AM | Novavax (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
06/20/2024
4:08 PM | Dubovsky Filip (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
1:35 PM | Novavax (Subject)
SK Bioscience Co., Ltd. (Filed by)
| Form SC 13G/A | |
06/06/2024
6:00 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
8:35 PM | Novavax (Filer)
| Form DEFA14A | |
05/20/2024
1:42 PM | Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
| Form DFAN14A | |
05/20/2024
5:09 AM | Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
| Form SC 13D/A | |
05/15/2024
8:15 PM | Dubovsky Filip (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
1:39 PM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
7:05 AM | Novavax (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024
7:07 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
3:53 PM | Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
| Form DFAN14A | |
05/07/2024
4:21 PM | Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
| Form DFAN14A | |
05/07/2024
1:43 PM | Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
| Form SC 13D/A | |
05/06/2024
3:43 PM | Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
| Form DFAN14A | |
05/06/2024
5:00 AM | Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
| Form PREC14A | |
04/29/2024
6:58 AM | Novavax (Filer)
| Form DEFA14A | |
04/29/2024
7:01 AM | Novavax (Filer)
| Form ARS | |
04/29/2024
6:54 AM | Novavax (Filer)
| Form DEF 14A | |
